Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
63 Cards in this Set
- Front
- Back
Micro Chapter 12
|
Streptococci and Enterococci
|
|
alpha hemolysis
|
partial hemolysis of blood agar (appears green)
|
|
beta hemolysis
|
complete hemolysis of blood agar (appears clear)
|
|
gamma hemolysis
|
no hemolysis observed
|
|
most important streptococcal pathogen to humans
|
GAS (S. pyogenes)
|
|
primary presenttion of GAS
|
acute pharyngitis
|
|
pyoderma
|
GAS infection of skin and soft tissues
|
|
delayed sequellae of GAS infections
|
acute glomerulonephritis and acute rheumatic fever
|
|
how are streptococcal pyoderma infections acquired
|
through break in skin/trauma
|
|
M protein
|
adhesin found in GAS that allows it to bind to keratinocytes
|
|
HA capsule
|
found in GAS and may facilitate binding to host receptor CD44 seen on pharyngeal epithelium as well as skin keratinocytes
|
|
impetigo
|
crusty honey colored lesions of mastoid air cells or middle ear indicitive of benign GAS infection
|
|
erysiplelas and cellulitis
|
caused by deep layers of skin becoming infected with GAS
|
|
consequence of GAS reaching fascial planes b/w skin and muscle
|
necrotizing fasciatis and myositis
|
|
enzymes secreted by GAS which resut in necrotizing fasciitis
|
proteases, hyaluronidase, Dnase, streptokinase
|
|
streptolysins S and O
|
lyse membranes of various host cells such as RBCs
|
|
describe the binding regions of the protein and what they do
|
proximally the C and D regions bind compliment control protein factor H which prevents opsinozation while distally B region binds fibrinogen which also interferes with compliment formation
|
|
why do prior exposures to GAS not protect from reinfection
|
although we can effectively form antibodies to the M protein, there are over 200 distinct M types meaning immuntiy to one will likely not prevent reinfection
|
|
how is the HA capsule protective of GAS
|
human CT has a lot of HA so a thick HA capsule camoflogues the GAS from immune detection
|
|
septicemia vs toxemia
|
septicemia is presece of bacteria in blood while toxemia is just the presense of toxins in the blood. Both can be deadly if untreated
|
|
scarlet fever
|
GAS associated toxemia
|
|
toxins responsible for scarlet fever
|
streptococcal pyrogenic exotoxins A,B, and C
|
|
superantigens seen in scarlet fever
|
SPE A and C
|
|
superantigens
|
produce large nonspecific T cell response resulting in massive cytokine release which can lead to shock
|
|
STSS (streptococcal toxic shock syndrome)
|
result of superantigens SPE A/C resulting in a widespread toxemia
|
|
only type of streptococcal infection that can lead to acute rheumatic fever
|
pharyngitis
|
|
jones criteria
|
symptoms appearing 1-4 weeks after strep throat that are indicitave of acute rheumatic fever. Include carditis, polyarthritis, chorea, subcutaneous nodules, and erythema marginatum
|
|
most common manifestations of acute rheumatic fever
|
carditis and polyarthritis
|
|
rheumatic heart disease
|
consequence of inflammation caused by rheumatic fever, results in mitral and aortic valvular scarring and stenosis
|
|
best way to prevent ARF
|
treat strep with antibiotics prior to large immune response
|
|
rheumatogenic strains of GAS
|
more commonly associated with rheumatic fever. May be due to cross reactivity between M proteins and tissues of the heart/brain/synovium etc…
|
|
nonsuppurative sequela of GAS that may follow pharyngitis or pyodermal infection and is unaffected by antibiotic tx
|
acute poststreptococcal glomerulonephritis
|
|
possible pathogenesis of acute poststreptococcal GN
|
immune complexes of strep proteins and antibodies attach to the glomerular basement membrane and leads to complement fixation resulting in kidney injury
|
|
erysiplelas
|
raised bright red patch of skin with sharply demarcated but rapidly advancing margin
|
|
rapid strep test detects
|
only group A antigen (GAS)
|
|
you cannot rule out strep throat until what
|
a neative throat culture is returned
|
|
how to distinguish asymptomatic GAS carrage in throat with viral pharyngitis from true GAS infection
|
you cant
|
|
for diagnosis of ARF and APSGN what evidence do you need, how do you get it
|
evidence of preceeding GAS infection. Have to do an antistreptolysin O titer, anti DNase titer, or streptozyme screen
|
|
resistance to penacillin in GAS
|
has not yet been seen
|
|
benzathine penacillin
|
longeracting penacillin that lowers risk of ARF but is administered in a painful injection
|
|
tx of GAS in penacillin allergic pt
|
erythromycin or other macrolide antibiotics
|
|
Group B strep
|
beta hemolytic, don’t cause significant disease in healthy people
|
|
GBS normally colonize
|
lower GI and female Genital tracts
|
|
GBS are problematic in
|
newborns
|
|
when are pregnant women tested for GBS, why?
|
week 35-37, if GBS is present during vaginal birth it can endanger the life of the child
|
|
GBS is a leading cause of what in newborns
|
sepsis and meningitis
|
|
how do GBS evade immune response
|
polysacchride capsule (type 3 most common in neonatal infections)
|
|
streptococci species that are similar to GAS but cannot cause rheumatic fever
|
Group C and G (S. dysgalactiae)
|
|
S. pneumoniae has what hemolysis pattern
|
alpha
|
|
virdans streptocicci
|
primarily alpha hemolytic, grow in oral cavity, are responsible for dental plaques and caries (S mutans and S sobrinus) can seed bloodstream and cause endocarditis
|
|
nutritionally variant streptococci
|
difficult to grow in lab, can cause complicated endocarditis
|
|
E faecalis and E faecium
|
medically important enterococci that cause UTI, wound infection, endocarditis, abdominal abscess , and bacteremia
|
|
how are enterococci differentiated from streptococci
|
resistance to high salt concentrations and bile found in GI
|
|
why are enterococci becoming more of a problem
|
hospital acquired oppurtunisitc infections of enterococcus are becoming resistant to the last line antibiotic for Gram + organisms vancomycin (VRE)
|
|
effect of penicillins on enterococci
|
bacteriostatic
|
|
synergistic antibiotic regemin to combact enterococci
|
penacillin and aminoglycosides
|
|
linezolid
|
bacterial protein synthesis inhibitor being used to treat VRE
|
|
daptomycin
|
lipopeptide that causes membrane leak, being used to treat VRE
|
|
tigecycline
|
tetracycline derivative used for VRE
|
|
dalfopristin-quinuupristin
|
antibiotic for VRE with limited usefullness due to emerging resistance and toxicity
|
|
S agalactiae
|
hallmark group B strep
|
|
Enterococci were also known as
|
Group D strep
|
|
group C and D srep mainly cause
|
respiratory and deep tissue infections
|